South Korean fabless manufacturer Dongwoon Anatech is seeking the approval of both the US and Korean Food and Drug Administration for the commercial rollout of its saliva-based glucose monitoring device after completing its first clinical trial in December.
WHAT IT DOES
The glucose monitoring device called D-SaLife, a product of six years of research and development, makes use of microcurrent...
Glooko, the maker of a digital platform for managing diabetes and other chronic diseases, announced today a $30 million Series D funding round led by Health Catalyst Capital. Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic also played a part in the raise.
WHAT IT DOES
The Palo Alto startup's app-based platform acts as a central hub for connected monitoring devices and other...
DarioHealth announced today that it is expanding its digital chronic-disease-management business beyond diabetes and hypertension with the purchase of Upright Technologies, a musculoskeletal (MSK) health company that specializes in connected posture correction devices and digital coaching.
The deal is expected to close on or around February 7, and will run DarioHealth $31 million to complete the...
Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes.
The FreeStyle Libre 2 system continuously measures glucose data every minute and can automatically alert users when their glucose is high or low without needing to scan the sensor.
It is worn on the back of the user’s upper arm for up to 14...
Shortly after acquiring smart insulin-pen-maker Companion Medical, Medtronic has officially launched the InPen device alongside integration with its Guardian Connect connected glucose monitoring (CGM) system.
Of note, Medtronic's InPen is the only smart insulin pen cleared by the FDA for use by people requiring multiple daily injections. It received that 510(k) back in 2016.
WHY IT MATTERS
With...
Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
New top-line data presented by Omada Health and researchers from the University of Nebraska Medical Center and Wake Forest University suggest that the chronic condition-management company's digital diabetes-prevention program can deliver clinically meaningful blood sugar reduction and weight loss over 12 months.
The PREDICTS randomized controlled trial was first announced in 2018, and enrolled...
A specialist clinic that’s claiming to be “the world’s first healthcare provider” to “employ remote continuous data monitoring” for diabetic patients has been officially opened in Dubai.
Following a soft launch in September, GluCare Integrated Diabetes Center – which has been developed in the United Arab Emirates (UAE) with partners in Silicon Valley – offers remote continuous data monitoring as...
A new study exploring the effectiveness of virtual health follow-ups using home-monitoring devices and mobile technology is currently being conducted by the Dubai Diabetes Centre (DDC) with the support of the Dubai Health Authority (DHA) in the United Arab Emirates.
Running until the end of December, the study is being carried out in collaboration with Cognitive Healthcare International (CHI), a...
New research examining patients with healed diabetic foot ulcers revealed that daily foot temperature monitoring can result in lower rates of hospitalization and foot ulcer recurrence in high-risk patients, according to a study in BMJ Open Diabetes Research & Care.
The study used Podimetrics SmartMats to take the temperature of participants’ feet and to scan for signs of inflammation. The...
.png?itok=pPElSbhQ)
.jpg?itok=f1hOAez1 "Following a soft launch in September, the GluCare Integrated Diabetes Center says it monitors the data of its patients in real-time, plus employs digital therapeutics.")
.jpg?itok=EPzLhvOT "The aim is to use the technology to track daily patient data and “plan interventional strategies in real-time to avoid complications of the disease,” the centre said.")
